Silhouette

Donald T Moir

Microbiotix, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Inhibitors of the viral nucleoprotein-polymerase co-factor interaction for human RSV and MPV
Microbiotix, Inc.
Principal Investigator
HHS 1 $285K 08/01/17 07/31/18
Inhibitors of the viral nucleoprotein-polymerase co-factor interaction for human RSV and MPV
Microbiotix, Inc.
Principal Investigator
HHS 1 $300K 08/01/16 07/31/17
Antibiotic potentiators maximizing the formation of open- channel OprF-type outer membrane porins
Microbiotix, Inc.
Principal Investigator
HHS 1 $287K 06/01/16 05/31/17
Antibiotic potentiators maximizing the formation of open- channel OprF-type outer membrane porins
Microbiotix, Inc.
Principal Investigator
HHS 1 $283K 06/15/15 05/30/16
Inhibitors of isoprenoid synthesis for antibacterial therapy
Microbiotix, Inc.
Principal Investigator
HHS 1 $300K 01/01/14 12/31/14
Aminoglycoside potentiators for P. aeruginosa therapy
Microbiotix, Inc.
Principal Investigator
HHS 1 $300K 12/01/13 11/30/14
Type III Secretion Inhibitors for Anti-Infective Therapy
Microbiotix, Inc.
Principal Investigator
HHS 2 $979K 08/01/13 07/31/14
Inhibitors of S. aureus bNOS for adjunctive therapy
Microbiotix, Inc.
Principal Investigator
HHS 1 $291K 07/01/13 06/30/14
Inhibitors of isoprenoid synthesis for antibacterial therapy
Microbiotix, Inc.
Principal Investigator
HHS 1 $300K 01/07/13 12/31/13
Aminoglycoside potentiators for P. aeruginosa therapy
Microbiotix, Inc.
Principal Investigator
HHS 1 $300K 12/01/12 11/30/13
Type III Secretion Inhibitors for Anti-Infective Therapy
Microbiotix, Inc.
Principal Investigator
HHS 2 $980K 08/01/12 07/31/13
Inhibitors of S. aureus bNOS for adjunctive therapy
Microbiotix, Inc.
Principal Investigator
HHS 1 $291K 07/01/12 06/30/13
Type III Secretion Inhibitors for Anti-Infective Therapy
Microbiotix, Inc.
Principal Investigator
HHS 2 $1MM 08/01/11 07/31/12
DNA Helicase and Primase Inhibitors for Biodefense
Microbiotix, Inc.
Principal Investigator
HHS 2 $915K 09/01/10 08/31/11
DNA Helicase and Primase Inhibitors for Biodefense
Microbiotix, Inc.
Principal Investigator
HHS 2 $871K 09/01/09 08/31/10
Therapeutics targeting fatty acid synthesis in P. aeruginosa
Microbiotix, Inc.
Principal Investigator
HHS 1 $292K 06/01/09 05/31/11
Discovery of B. pseudomallei therapeutics for Biodefense
Microbiotix, Inc.
Principal Investigator
HHS 2 $1.05MM 09/01/08 08/31/10
Therapeutics targeting fatty acid synthesis in P. aeruginosa
Microbiotix, Inc.
Principal Investigator
HHS 1 $300K 06/15/08 05/31/09
Discovery of B. pseudomallei therapeutics for Biodefense
Microbiotix, Inc.
Principal Investigator
HHS 2 $1.17MM 09/01/07 08/31/08
Type III Secretion Inhibitors for Anti-Infective Therapy
Microbiotix, Inc.
Principal Investigator
HHS 1 $315K 08/01/07 07/31/09
Discovery of B. pseudomallei therapeutics for Biodefense
Microbiotix, Inc.
Principal Investigator
HHS 2 $994K 09/15/06 08/31/07
DNA helicase and primase inhibitors for biodefense
Microbiotix, Inc.
Principal Investigator
HHS 1 $581K 08/01/06 07/31/08
Type III Secretion Inhibitors for Anti-Infective Therapy
Microbiotix, Inc.
Principal Investigator
HHS 1 $339K 08/01/06 07/31/07
DNA helicase and primase inhibitors for biodefense
Microbiotix, Inc.
Principal Investigator
HHS 1 $565K 08/01/05 07/31/06
Sensing Biowarfare Agents by Surface Enhanced Raman
Microbiotix, Inc.
Principal Investigator
HHS 1 $369K 07/01/05 12/31/06
Discovery of B. pseudomallei Therapeutics for Biodefense
Microbiotix, Inc.
Principal Investigator
HHS 1 $350K 07/01/04 06/30/05
Discovery of B. pseudomallei Therapeutics for Biodefense
Microbiotix, Inc.
Principal Investigator
HHS 1 $308K 11/01/03 06/30/04